← Back to Search

Acupuncture for Stroke (HHSCSTROKEAC Trial)

N/A
Waitlist Available
Led By Enoch K Ho, MPh
Research Sponsored by Hamilton Health Sciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age of the patients between 55 to 70 years old
Time from stroke onset 12 months but less than 18 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 3 weeks
Awards & highlights

HHSCSTROKEAC Trial Summary

The purpose of this study is to investigate if acupuncture is more effective than sham treatment in reducing lower extremity spasticity, and improving gait speed in the chronic phase of stroke recovery.

Eligible Conditions
  • Stroke

HHSCSTROKEAC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

HHSCSTROKEAC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 3 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline in 2 minute walk test
Secondary outcome measures
Change from baseline in ankle range of motion
Change from baseline in self report ankle tightness

Side effects data

From 2013 Phase 1 & 2 trial • 104 Patients • NCT01305811
2%
Serious unexpected
2%
Pain on needling
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bi-Weekly Acupuncture
Wait List

HHSCSTROKEAC Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: AcupunctureExperimental Treatment1 Intervention
True acupuncture
Group II: Sham needlePlacebo Group1 Intervention
Retractable acupuncture needles will be used. No true transcutaneous needling through the skin

Find a Location

Who is running the clinical trial?

Hamilton Health Sciences CorporationLead Sponsor
368 Previous Clinical Trials
300,953 Total Patients Enrolled
11 Trials studying Stroke
48,790 Patients Enrolled for Stroke
Enoch K Ho, MPhPrincipal InvestigatorHamilton Health Sciences Corporation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025